CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Thursday reported a loss of $200 million in its third quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 51 cents.
The results exceeded Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $2.15 per share.
The biotechnology company posted revenue of $1.02 billion in the period, also surpassing Street forecasts. Nine analysts surveyed by Zacks expected $860.1 million.
Moderna expects full-year revenue in the range of $1.6 billion to $2 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNA at https://www.zacks.com/ap/MRNA
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
